Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacific Biosciences of California Inc (NASDAQ:PACB)

Delayed Data
As of Feb 10
 -0.67 / -7.09%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Pacific Biosciences of California, Inc. develops, manufactures and markets an integrated platform for genetic analysis. It has developed a technology to study the synthesis and regulation of DNA combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry, and optics. The company has developed a technology platform called single molecule, real-time, or SMRT, technology to study the synthesis and regulation of DNA. SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events. Its initial focus is on DNA sequencing market where a third generation sequencing platform using proprietary SMRT technology, the PacBio RS. The PacBio RS a third generation sequencing instrument that provides real-time information at the single molecule level which includes instrument platform that uses its proprietary consumables, including its SMRT Cells and reagent kits, providing a complete solution to the customer. The company was founded by Stephen Turner and Joseph V. Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Contact Information

Pacific Biosciences of California, Inc.
1380 Willow Road
Menlo Park California 94025
P:(650) 521-8000
Investor Relations:
(650) 521-8450



Other institutional45.55%
Individual stakeholders18.17%
Mutual fund holders12.40%

Top Executives

Mike W. HunkapillerExecutive Chairman, President & CEO
Susan K. BarnesExecutive VP, Chief Financial & Accounting Officer
Stephen W. TurnerChief Technology Officer & Vice President
Jonas KorlachChief Scientific Officer
James Michael PhillipsSenior Vice President-Research & Development